Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion

Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion - Comparative study of remifentanil-propofol with dexmedetomidine versus without dexmedetomidine for tracheobronchial stent insertion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004546

Enrollment

Registered

2010-11-12

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with tracheobronchial stenosis undergoing tracheobronchial stent insertion under general anesthesia

Interventions

conventional anesthetic management with propofol and remifentanil combined with conventional anesthetic and dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patient undergoing tracheobronchial stent insertion under general anesthesia 2)Patient over 20 years old 3)Written informed consent from the patient

Exclusion criteria

Exclusion criteria: 1)Patients with bradycardia(HR<50/min) 2)Patients with 2 or 3 AVblock 3)Patients with heart failure 4)Patients with nustable angina pectoris 5)Patients with severe liver disfunction 6)Patients with severe renal disfunction

Design outcomes

Primary

Measure	Time frame
hemodynamics,respiratory condition,sedative condition,total dose of anesthesia,duration of anesthetic induction,duration of emergence	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026